Avaleht › Südamepuudulikkus › Virginia › Richmond
Südamepuudulikkus kliinilised uuringud linnas Richmond, VA
16 uuringut haiguse Südamepuudulikkus jaoks otsivad osalejaid linnas Richmond ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
VärbamineFaas 3
- Research Site, Midlothian · 11 mi kaugusel
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
VärbamineFaas 3
- Richmond, VA Investigative Site 10069, Richmond
- Richmond, VA Investigative Site 10067, Richmond
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Värbamine
- Virginia Commonwealth University, Richmond
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
VärbamineVaatlusuuring
- VCU Medical Center, Richmond
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
VärbamineFaas 3
- Virginia Commonwealth University, Richmond
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Värbamine
- Richmond VA Medical Center, Richmond, VA, Richmond
Assessment of CCM in HF With Higher Ejection Fraction
Värbamine
- Bon Secours St. Mary's, Richmond
- Bon Secours St. Mary's, Richmond
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
VärbamineFaas 3
- FIN-10093, Richmond, VA, Richmond
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
VärbamineFaas 1/2
- Virginia Commonwealth University, Richmond
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
VärbamineFaas 3
- Virginia Commonwealth University, Richmond
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Värbamine
- HCA Chippenham Medical Center, Richmond
His-Bundle Corrective Pacing in Heart Failure
Värbamine
- Virginia Commonwealth University, Richmond
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
VärbamineVaatlusuuring
- Virginia Commonwealth University School of Medicine, Richmond
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
VärbamineFaas 2/3
- Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
Left vs Left Randomized Clinical Trial
Värbamine
- Virginia Commonwealth University, Richmond
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
VärbamineFaas 4
- Virginia Commonwealth University, Richmond
Südamepuudulikkus uuringud teistes linnades
- New York City, NY51 uuringut
- Boston, MA44 uuringut
- Dallas, TX42 uuringut
- Houston, TX36 uuringut
- Cleveland, OH33 uuringut
- Chicago, IL31 uuringut
- Philadelphia, PA31 uuringut
- San Francisco, CA29 uuringut
- St. Louis, MO26 uuringut
- Durham, NC26 uuringut
- Kansas City, MO25 uuringut
- Atlanta, GA25 uuringut
Muud uuringud linnas Richmond
- Rinnavähk26 uuringut
- Mitteväikerakuline kopsuvähk25 uuringut
- Eesnäärmevähk19 uuringut
- Kopsuvähk14 uuringut
- Käär- ja pärasoolevähk13 uuringut
- Kardiovaskulaarsed haigused13 uuringut
- Steatoosne maksahaigus12 uuringut
- Äge müeloidne leukeemia12 uuringut
- Pea ja kaela lameepiteeli kartsinoom12 uuringut
- Metastaatiline vähk12 uuringut
- Melanoom11 uuringut
- Rasvumine11 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.